GLP-1 drugs for diabetes and weight loss may influence patients’ cancer risk, usually lowering it but sometimes possibly ...

In people with recently diagnosed type 2 diabetes and no prior cardiovascular disease, self-reported physical activity ...

With the stock currently trading at Rs 3,154.10, GlaxoSmithKline Pharmaceuticals demonstrates a positive movement in today's session.

With the stock currently priced at Rs 2,724.90, GlaxoSmithKline Pharmaceuticals shows significant activity in today's session ...

Influenza Pipeline Summary. DelveInsight’s Influenza Emerging Drugs report highlights innovative therapies advancing the ...

The pharmaceutical drug delivery market is entering a transformative phase, projected to grow from USD 1,949.4 billion in ...

Pharmaceutical technology exports have exceeded KRW 10 trillion this year, according to an Aug. 19 report based on Global ...

As weight loss solutions continue to proliferate, the enduring debate over whether obesity stems from personal responsibility ...

Arab Finance: GlaxoSmithKline Egypt (GSK–Egypt) logged consolidated net profits for controlling interest of EGP 65.060 ...

The research, done in mice and in human cells, shows that a protein called STUB1 restrains the immune system’s elite ...

HHS Secretary Robert F. Kennedy Jr, is a well-known vaccine critic, but it is way past time for human health to be put on a ...

China’s biotechnology sector has established a bright future by focusing not on breakthrough cures and treatments but on ...